Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial건강한 일본 성인을 대상으로 한 NVX-CoV2373(TAK-019) 백신의 안전성 및 면역원성: I/II상 무작위 대조 시험 중간 보고Clinical Trial Published on 2022-05-262022-09-12 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] 95% confidence interval Adults adverse event AEs age AMED anti-SARS-CoV-2 immune response antibody ARMS company conducted COVID-19 Data analysis demonstrated development dose enrolled evaluated Follow-up geometric healthy IgG immune response immunogenicity injection injection site pain Interim Japan Japanese Japanese adults Limited NVX-CoV2373 occurred outcome participant Participants pharmaceutical Placebo placebo-controlled trial Protein Randomized Randomized controlled trial receive reported robust Safety SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 nanoparticle vaccine SARS-CoV-2 vaccine screened second dose seroconversion rate serum IgG stratified subject Takeda vaccination Vaccine [DOI] 10.1016/j.vaccine.2022.04.035 PMC 바로가기 [Article Type] Clinical Trial
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data이종 불활성화 및 아데노바이러스 매개 COVID-19 백신의 면역원성: 실제 데이터Article Published on 2022-05-202022-09-11 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] adenoviral-vectored vaccine adenoviral-vectored vaccines Anti-RBD IgG AZD1222 B.1.1.7 B.1.351 B.1.617.2 CMIA CoronaVac country COVID-19 COVID-19 vaccine elicited ELISA enrolled enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay followed by group Heterologous heterologous vaccine homologous IgG immunoassay immunogenicity inactivated Limited Microparticle neutralization test Neutralizing activity neutralizing antibody participant recipient recipients regimen response SARS-CoV-2 SARS-CoV-2 variants sera serum sample serum samples subset surrogate virus neutralization test sVNT tested the SARS-CoV-2 Vaccine variant variants variants of concern virus neutralization test was tested Wuhan Wuhan strain [DOI] 10.1016/j.vaccine.2022.04.043 PMC 바로가기 [Article Type] Article
E-Consent-a guide to maintain recruitment in clinical trials during the COVID-19 pandemicRandomized Controlled Trial Published on 2022-05-122022-10-05 Journal: Trials [Category] COVID19(2023년), SARS, 임상, [키워드] Analysis approved average clinical trial Consent Consent management Course COVID-19 crisis COVID-19 pandemic Critical described e-Consent. enrolled ethics committee face-to-face interaction help implementation Informed Informed consent Limited lockdown maintain offered overcome pandemic pathway Patient performed platform positive Prostate cancer Prostate-cancer protocol randomized clinical trial recruited recruitment Regional Regulatory remote required Research researcher risk of COVID-19 Support Transmission Trial [DOI] 10.1186/s13063-022-06333-6 PMC 바로가기 [Article Type] Randomized Controlled Trial
duper is a null mutation of Cryptochrome 1 in Syrian hamstersduper는 시리아 햄스터의 Cryptochrome 1의 null 돌연변이입니다.Article Published on 2022-05-032022-09-11 Journal: Proceedings of the National Academy of Sciences of [Category] 변종, [키워드] allele Biomedical research Bioscience caused circadian clock circadian rhythm CLOCK conserved Cry1 Cry1-null Cryptochrome dataset de novo facilitate fast homozygosity mappings Genetic genome assembly genomic hamster hamsters homozygosity mapping limb Limited Mesocricetus Mutation Oxford Nanopore Technologies Phase shift Protein recessive mutation resource sequencing data short circadian period length. Syrian hamster genome [DOI] 10.1073/pnas.2123560119 PMC 바로가기 [Article Type] Article
COVID-19 article altimg-small=kintcovid_s.svg altimg=kintcovid_o.svg>The COVID-19 Pandemic Identifies Significant Global Inequities in Hemodialysis Care in Low and Lower-Middle Income Countries—An ISN/DOPPS SurveyResearch article Published on 2022-05-012022-10-05 Journal: Kidney International Reports [Category] 진단, [키워드] advocacy Affect affected Asymptomatic Bank Care Chronic hemodialysis Comparisons conducted contribute country COVID-19 COVID-19 pandemic diagnostic test dialysis exacerbating hospitalized patient ICU identify income Inequity intensive care Kidney failure less Limited Masks mechanical ventilation Nephrology outcomes pandemic Patient pattern Personal protective equipment PPE Practice regions reported required resource Respirator respondent response Result returned SARS-CoV-2 Significant staff survey Treatment with COVID-19 [DOI] 10.1016/j.ekir.2022.02.027 [Article Type] Research article
An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey터키 의료 종사자의 코로나백 2차 접종 후 항체 반응 및 BNT162b2 또는 코로나백 추가 접종 후 체액성 반응 분석Article Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] Fulltext, MERS, 변종, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration age Analysis Anti-RBD IgG anti-receptor-binding domain antibody antibody levels Antibody Response asked blood draw BNT162b2 booster booster dose booster doses chronic disease circulating variants Complete CoronaVac coronavirus dose evaluated Follow-up groups healthcare worker Healthcare workers Heterologous heterologous vaccination homologous or heterologous humoral Humoral response IgG Immunoglobulin Immunoglobulin G Inactivated vaccine independent predictor independent predictors levels of antibody Limited Messenger RNA Odds ratio participant Participants prospective cohort study Quantitative questionnaire RBD reduction respiratory risk SARS-CoV-2 second dose Seropositivity severe acute respiratory syndrome Coronavirus single booster dose the median Turkey university hospital vaccination Vaccine waning immunity were infected were measured [DOI] 10.1002/jmv.27620 PMC 바로가기 [Article Type] Article
Seroepidemiology of SARS-CoV-2 in pediatric population during a 16-month period prior to vaccination백신 접종 전 16개월 동안 소아 집단에서 SARS-CoV-2의 혈청역학Article Published on 2022-05-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age antibody Antibody titer Antibody titers children collected Community coronavirus coronavirus disease Coronavirus disease 2019 correlation COVID-19 COVID-19 infection cut-off diagnosed Elecsys Epidemic epidemic waves except for females group groups hospital Hospitalized Immunity immunization Infection investigated Limited lowest male median median age no significant differences nucleocapsid protein pandemic pediatric Randomly reported representing respiratory SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody Seroepidemiology seropositive Seropositivity serum sample serum samples severe acute respiratory syndrome Coronavirus significant difference significantly higher study period Support Total vaccination was related [DOI] 10.1002/jmv.27608 PMC 바로가기 [Article Type] Article
Elevated CD21 low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency증가된 CD21 낮은 B 세포 빈도는 공통 가변성 면역결핍증 환자에서 SARS-CoV-2에 대한 화이자-바이오엔텍 BNT162b2 mRNA 백신에 대한 면역 저하의 지표입니다Clinical Trial Published on 2022-05-012022-09-12 Journal: Journal of Clinical Immunology [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] affected Against analyzed antibody B-cell baseline BNT162b2 mRNA BNT162b2 mRNA vaccination BNT162b2 mRNA vaccine CD21 CD21low B-cells CD4 cell count central memory clinical trial cohort of patient common correlated COVID-19 COVID-19 vaccination CVID demonstrated dose Frequency healthy control Humoral immunity IFN-γ IgG immune response immunocompromised individuals immunodeficiency Limited median titer memory B-cell Open-label Patient patients patients with CVID Pfizer-BioNTech Pfizer-BioNTech BNT162b2 mRNA vaccine Poor positive proportion reached reduced response SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 spike-specific second dose selected seroconverted seronegative significantly single-center T cell response T-cell the vaccine threshold vaccine responses variable were assessed [DOI] 10.1007/s10875-022-01244-2 PMC 바로가기 [Article Type] Clinical Trial
Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments다른 암 치료를 받는 암 환자에서 SARS-CoV-2 mRNA 백신에 대한 제한된 T 세포 반응Article Published on 2022-05-012022-09-12 Journal: European journal of cancer (Oxford, England : 1990 [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] administration adverse event anti-S anti-S IgG blood sample Cancer cancer treatment CD4+ CD4+ T cell CD8+ CD8+ T cell cellular response Chemotherapy collected complement complications conducted control group COVID-19 COVID-19 case cut-off defined demonstrated determine develop diagnose dose driven by enrolled first dose follow-up period HCW Health care worker high risk humoral Humoral response Immunotherapy inhibitor involved kinase Limited magnitude mRNA vaccine mRNA-1273 mRNA-1273 vaccine Patient patient reported outcome Patients with cancer receiving reported SARS-CoV-2 second dose significantly higher significantly lower single-center study Solid solid tumour Solid tumours T cell response T cells treated vaccination Vaccine vaccine dose [DOI] 10.1016/j.ejca.2022.02.017 PMC 바로가기 [Article Type] Article
Limited cross-species transmission and absence of mutations associated with SARS-CoV-2 adaptation in cats: A case study of infection in a small household setting고양이의 SARS-CoV-2 적응과 관련된 제한된 종간 전파 및 돌연변이 부재: 소규모 가정 환경에서의 감염 사례 연구Article Published on 2022-05-012022-09-11 Journal: Transboundary and emerging diseases [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] absence adaptation adaptive Anosmia Asymptomatic cat cats chain Clinical signs close contact collected Concentration concentrations Course COVID-19 Cross-species transmission Diagnosis Epidemiology fatigue flat highlight Human human SARS-CoV-2 strain human SARS-CoV-2 strains immunosuppressive Infection infections initial Interaction investigated Limited loss of taste Mutation naïve natural infection retroviral RT-PCR SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 strains SARS-CoV-2 transmission Seroconversion Serological testing sneezing Support Swab symptom onset Taste titre Transmission Viral RNA virus virus titre virus transmission were measured whole-genome sequencing [DOI] 10.1111/tbed.14132 PMC 바로가기 [Article Type] Article